Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DaVita Inc V.DVA


Primary Symbol: DVA

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.


NYSE:DVA - Post by User

Post by DTrader706on May 14, 2018 9:43pm
137 Views
Post# 28030177

I'm done

I'm done
Something isn't right with this company. Go to their site, and you will see they have two executives and one of them is the accountant. All the costs savings came from people leaving.
It seems they are aggressively trying to make themselves out to be an MJ company and all their rev comes through pain cream sales. Too much smoke and mirrors for me!
My friend is a compound pharmacist and he said Lipoderm is the leader in transdermal technologies and their sales makes this company look amateurish.
Hope is not a good strategy, dig deeper and you will see what I am saying.
Anyway, I'm out of the stock and no reason to be on this board anymore.
Good luck
<< Previous
Bullboard Posts
Next >>